Reconfigurable Multi-Organ-on-a-Chip System Reliably Evaluates Chemotherapy Toxicity (2 of 5) (IMAGE)

American Association for the Advancement of Science (AAAS)

Reconfigurable Multi-Organ-on-a-Chip System Reliably Evaluates Chemotherapy Toxicity (2 of 5)

Caption

Hesperos's platform for measuring cardiac electrical activity (similar to an EKG) in the reconfigurable body-on-a-chip system. A custom compact measurement system for measuring the electrical activity of cardiac tissues fits entirely on a small desk or table. The reconfigurable body-on-a-chip system shown in the lower left (outside of the measurement platform) is placed in the heated stage (lower right, shown with a body-on-a-chip system in place) and connected to the measurement system and to a standard computer. Users can see real-time data on the screen during measurements, similar to watching an EKG monitor. This material relates to a paper that appeared in the Jun. 19, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by C.W. McAleer at Hesperos Inc. in Orlando, FL; and colleagues was titled, "Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics."

Credit

Hesperos

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.